Suivre
Ariel Dora Stern
Ariel Dora Stern
Associate Professor, Harvard Business School
Adresse e-mail validée de hbs.edu - Page d'accueil
Titre
Citée par
Citée par
Année
Physician beliefs and patient preferences: a new look at regional variation in health care spending
D Cutler, JS Skinner, AD Stern, D Wennberg
American Economic Journal: Economic Policy 11 (1), 192-221, 2019
4102019
Will the stork return to Europe and Japan? Understanding fertility within developed nations
J Feyrer, B Sacerdote, AD Stern
Journal of Economic Perspectives 22 (3), 3-22, 2008
2972008
Adaptive platform trials: definition, design, conduct and reporting considerations
Nature Reviews Drug Discovery 18 (10), 797-807, 2019
2372019
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
S Gerke, AD Stern, T Minssen
NPJ digital medicine 3 (1), 94, 2020
1362020
Innovation under regulatory uncertainty: Evidence from medical technology
AD Stern
Journal of public economics 145, 181-200, 2017
1302017
Evaluating the impact of the Baby-Friendly Hospital Initiative on breast-feeding rates: a multi-state analysis
SS Hawkins, AD Stern, CF Baum, MW Gillman
Public health nutrition 18 (2), 189-197, 2015
1212015
Did the rust belt become shiny? A study of cities and counties that lost steel and auto jobs in the 1980s [with comments]
J Feyrer, B Sacerdote, AD Stern, A Saiz, WC Strange
Brookings-Wharton Papers on Urban Affairs, 41-102, 2007
1162007
Compliance with the Baby-Friendly Hospital Initiative and impact on breastfeeding rates
SS Hawkins, AD Stern, CF Baum, MW Gillman
Archives of Disease in Childhood-Fetal and Neonatal Edition 99 (2), F138-F143, 2014
832014
Quantifying the use of connected digital products in clinical research
C Marra, JL Chen, A Coravos, AD Stern
NPJ digital medicine 3 (1), 50, 2020
782020
Advancing digital health applications: priorities for innovation in real-world evidence generation
AD Stern, J Brönneke, JF Debatin, J Hagen, H Matthies, S Patel, I Clay, ...
The Lancet Digital Health 4 (3), e200-e206, 2022
682022
The impact of the entry of biosimilars: evidence from Europe
FM Scott Morton, AD Stern, S Stern
Review of Industrial Organization 53, 173-210, 2018
682018
Do state breastfeeding laws in the USA promote breast feeding?
SS Hawkins, AD Stern, MW Gillman
J Epidemiol Community Health 67 (3), 250-256, 2013
652013
Limits on use of health economic assessments for rare diseases
HI Hyry, AD Stern, TM Cox, JCP Roos
QJM: An International Journal of Medicine 107 (3), 241-245, 2014
592014
Health app policy: international comparison of nine countries’ approaches
A Essén, AD Stern, CB Haase, J Car, F Greaves, D Paparova, S Vandeput, ...
NPJ digital medicine 5 (1), 31, 2022
552022
Remote patient monitoring—overdue or overused?
K Mecklai, N Smith, A Stern, DB Kramer
N Engl J Med, 2021
542021
Challenges and opportunities in software-driven medical devices
WJ Gordon, AD Stern
Nature biomedical engineering 3 (7), 493-497, 2019
412019
How economics can shape precision medicines
AD Stern, BM Alexander, A Chandra
Science 355 (6330), 1131-1133, 2017
402017
Cybersecurity features of digital medical devices: an analysis of FDA product summaries
AD Stern, WJ Gordon, AB Landman, DB Kramer
BMJ open 9 (6), e025374, 2019
392019
Lessons from the impact of price regulation on the pricing of anticancer drugs in Germany: study assesses the effects of female political representation on mortality among …
VD Lauenroth, AS Kesselheim, A Sarpatwari, AD Stern
Health Affairs 39 (7), 1185-1193, 2020
382020
Regulatory considerations to keep pace with innovation in digital health products
J Torous, AD Stern, FT Bourgeois
NPJ Digital Medicine 5 (1), 121, 2022
312022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20